CEACAM5 and neoplasm: The levels of tumor markers were dramatically lowered after treatment (p< 0.05), and Group B had lower expression levels of CA19-9, CA242, and CEA than Group A at 3, 6 and 12 months after treatment, with statistically significant differences (p< 0.05).